Cargando…

First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation

BACKGROUND: In the era of immunotherapy, autologous stem cell transplantation (ASCT) in first-line therapy in patients with mantle cell lymphoma (MCL) has been a controversial topic. This report aimed to explore the association between ASCT and MCL survival through a systematic review with meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hailing, Shi, Xiao, Fang, Huizi, Cao, Lei, Miao, Yi, Zhao, Xiaoli, Wu, Wei, Xu, Wei, Li, Jianyong, Fan, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130771/ https://www.ncbi.nlm.nih.gov/pubmed/35646653 http://dx.doi.org/10.3389/fonc.2022.881346

Ejemplares similares

Conventional Treatments Cannot Improve Outcomes of Early-Stage Primary Breast Marginal Zone Lymphoma
por: Liu, Hailing, et al.
Publicado: (2021)

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
por: Kim, Seok Jin, et al.
Publicado: (2023)

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing
por: Dai, Luomengjia, et al.
Publicado: (2023)

Autologous stem cell transplantation for mantle cell lymphoma – single centre experience
por: Szcześniak, Magdalena, et al.
Publicado: (2013)

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients
por: Wang, Tao, et al.
Publicado: (2021)

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
por: Ekberg, Sara, et al.
Publicado: (2022)

Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
por: Yan, Fengting, et al.
Publicado: (2017)

Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
por: Wu, Aaron, et al.
Publicado: (2020)

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant
por: Herr, Megan M., et al.
Publicado: (2019)

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma
por: Rather, Gulam M., et al.
Publicado: (2019)

Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2022)

Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
por: Mohammad, Farhan, et al.
Publicado: (2017)

Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas
por: Sethi, Shenon, et al.
Publicado: (2021)

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells
por: Zhang, Qian, et al.
Publicado: (2019)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
por: Wang, Hongyu, et al.
Publicado: (2023)

ASTCT, CIBMTR and EBMT Clinical Practice recommendations for transplant and cellular therapies in mantle cell lymphoma.
por: Munshi, Pashna N., et al.
Publicado: (2021)

Stem cell transplant for mantle cell lymphoma in Taiwan
por: Wang, Yu-Hung, et al.
Publicado: (2022)

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
por: Manni, Sabrina, et al.
Publicado: (2021)

A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma
por: Zeng, Qiang, et al.
Publicado: (2023)

G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models
por: Zhou, Lixia, et al.
Publicado: (2021)

Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma
por: Locke, Clifford B, et al.
Publicado: (2020)

CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review
por: Ye, Mingyu, et al.
Publicado: (2022)

Educational Case: Mantle Cell Lymphoma
por: Mai, Brenda, et al.
Publicado: (2020)

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
por: Gao, Hongye, et al.
Publicado: (2022)

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China
por: Guo, Wei, et al.
Publicado: (2022)

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
por: Huang, Zhenghua, et al.
Publicado: (2023)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
por: Zhang, Jing, et al.
Publicado: (2022)

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018)

Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma
por: Bouard, Louise, et al.
Publicado: (2022)

P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA
por: Qu, Chang-Ju, et al.
Publicado: (2023)

Clinicopathologic study of mantle cell lymphoma with epstein-barr virus infection: A case series and literature review
por: Li, Xiaoju, et al.
Publicado: (2022)

Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas – a single centre experience
por: Boltezar, Lucka, et al.
Publicado: (2016)

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
por: Miao, Yi, et al.
Publicado: (2019)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation
por: Colita, Andrei, et al.
Publicado: (2019)

Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma
por: Miao, Yi, et al.
Publicado: (2019)

Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report
por: Liu, Wanying, et al.
Publicado: (2022)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
por: Wu, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e55dlv83673du5ftkhl907lk3c